Geneos Wealth Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-100
| Closed | -$6K | – | 2597 |
|
2022
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 2261 |
|
2021
Q4 | $8K | Sell |
100
-202,776
| -100% | -$16.2M | ﹤0.01% | 2253 |
|
2021
Q3 | $18.5M | Buy |
202,876
+202,776
| +202,776% | +$18.5M | 0.71% | 27 |
|
2021
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 2222 |
|
2021
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 2456 |
|
2020
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 2292 |
|
2020
Q3 | $6K | Sell |
100
-120,417
| -100% | -$7.23M | ﹤0.01% | 2104 |
|
2020
Q2 | $8.54M | Buy |
120,517
+120,334
| +65,756% | +$8.53M | 0.48% | 41 |
|
2020
Q1 | $7K | Sell |
183
-101,270
| -100% | -$3.87M | ﹤0.01% | 1925 |
|
2019
Q4 | $6.35M | Buy |
101,453
+101,270
| +55,339% | +$6.34M | 0.34% | 72 |
|
2019
Q3 | $7K | Hold |
183
| – | – | ﹤0.01% | 1994 |
|
2019
Q2 | $9K | Hold |
183
| – | – | ﹤0.01% | 1928 |
|
2019
Q1 | $10K | Hold |
183
| – | – | ﹤0.01% | 1830 |
|
2018
Q4 | $7K | Sell |
183
-57,450
| -100% | -$2.2M | ﹤0.01% | 1868 |
|
2018
Q3 | $4.01M | Buy |
57,633
+57,450
| +31,393% | +$4M | 0.27% | 107 |
|
2018
Q2 | $10K | Hold |
183
| – | – | ﹤0.01% | 1709 |
|
2018
Q1 | $10K | Hold |
183
| – | – | ﹤0.01% | 1632 |
|
2017
Q4 | $10K | Sell |
183
-32,300
| -99% | -$1.77M | ﹤0.01% | 1623 |
|
2017
Q3 | $1.99M | Buy |
32,483
+32,300
| +17,650% | +$1.98M | 0.2% | 124 |
|
2017
Q2 | $9K | Hold |
183
| – | – | ﹤0.01% | 1561 |
|
2017
Q1 | $8K | Hold |
183
| – | – | ﹤0.01% | 1545 |
|
2016
Q4 | $7K | Hold |
183
| – | – | ﹤0.01% | 1527 |
|
2016
Q3 | $8K | Buy |
183
+100
| +120% | +$4.37K | ﹤0.01% | 1429 |
|
2016
Q2 | $3K | Hold |
83
| – | – | ﹤0.01% | 1604 |
|
2016
Q1 | $3K | Buy |
+83
| New | +$3K | ﹤0.01% | 1589 |
|